Experiments involving in vivo injections of the Piezo1 agonist Yoda1 or antagonist GsMtx4 in a mouse model of hypertension led to the conclusion that Piezo1 activation in platelets causes platelet hyperactivation and increases the risk of thrombosis. Here, PIEZO1 is linked to hypertensive disorder.